Topical corticosteroids in dermatology

被引:70
|
作者
Mehta, Aayushi B. [1 ]
Nadkarni, Nitin J. [1 ]
Patil, Sharmila P. [1 ]
Godse, Kiran V. [1 ]
Gautam, Manjyot [1 ]
Agarwal, Shweta [1 ]
机构
[1] DY Patil Sch Med, Dept Dermatol, Navi Mumbai, Maharashtra, India
关键词
Glucocorticoid receptors; hydrocortisone; steroid-phobia; tachyphylaxis; topical corticosteroids; GLUCOCORTICOID-RECEPTOR; DOUBLE-BLIND; LONG-TERM; TACHYPHYLAXIS; PSORIASIS; STEROIDS; RISK; SKIN; 0.05-PERCENT; DERMATITIS;
D O I
10.4103/0378-6323.178903
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Since their introduction, topical corticosteroids have become indispensable in the treatment of various dermatoses. Hydrocortisone was the first compound. Modifications in the basic structure generated in vivo activity and thus different topically active compounds were discovered. Apart from the Stoughton vasoconstrictor assay, various other methods are used for potency assessment of topical corticosteroids. Topical corticosteroides are classified based upon potency and action of these molecules. Mechanism of action at the cellular level and indications of topical corticosteroid use have been discussed. Various adverse effects often occur as an extension of their activity combined with inappropriate usage. Tachyphylaxis and contact allergy are potential problems in clinical practice. Newer compounds with improved risk-benefit ratio are available.
引用
收藏
页码:371 / 378
页数:8
相关论文
共 50 条
  • [1] Topical Corticosteroids in Dermatology
    Tadicherla, Sujatha
    Ross, Kate
    Shenefelt, Philip D.
    Fenske, Neil A.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (12) : 1093 - 1105
  • [2] A story of topical corticosteroids in dermatology
    Thompson, D. A.
    Cave, B. L.
    Barkham, M. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 : 65 - 65
  • [3] TOPICAL CORTICOSTEROIDS USAGE IN DERMATOLOGY
    UPPAL, R
    SHARMA, SC
    BHOWMIK, SR
    SHARMA, PL
    KAUR, S
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1991, 29 (02) : 48 - 50
  • [4] THE USE AND ABUSE OF TOPICAL CORTICOSTEROIDS IN DERMATOLOGY
    HALLAM, NF
    [J]. SCOTTISH MEDICAL JOURNAL, 1980, 25 (04) : 287 - 291
  • [5] Pimecrolimus versus topical corticosteroids in dermatology
    Korfitis, Chrysovalantis
    Gregoriou, Stamatis
    Rallis, Efstathios
    Rigopoulos, Dimitris
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (10) : 1565 - 1573
  • [6] Topical corticosteroids in 1952, a revolution in dermatology
    Tilles, G
    [J]. PRESSE MEDICALE, 2005, 34 (15): : 1111 - 1112
  • [7] The rise and fall of topical corticosteroids in dermatology
    Coelho, R.
    Levell, N. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 142 - 142
  • [8] Evaluation of the Atrophogenic Potential of Topical Corticosteroids in Pediatric Dermatology Patients
    Hong, Esther
    Smith, Saxon
    Fischer, Gayle
    [J]. PEDIATRIC DERMATOLOGY, 2011, 28 (04) : 393 - 396
  • [9] Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach
    Das, Anupam
    Panda, Saumya
    [J]. INDIAN JOURNAL OF DERMATOLOGY, 2017, 62 (03) : 237 - 250
  • [10] New and established topical corticosteroids in dermatology: Clinical pharmacology and therapeutic use
    Brazzini B.
    Pimpinelli N.
    [J]. American Journal of Clinical Dermatology, 2002, 3 (1) : 47 - 58